No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
1 | general cells |
IFO50038 |
U-937 |
human |
pleural effusion |
lymphoma, diffuse histiocytic, monocyte-like characteristics |
|
2 | general cells |
IFO50099 |
F2408-B812 |
rat |
embryonic fibroblast |
HGPRT-deficient line from F2408 (IFO 50015). This cell line exhibits temperature sensitive phenotype for transformation by Moloney MSV. |
|
3 | general cells |
IFO50364 |
L6 |
rat |
skeletal myoblast |
skeletal muscle myoblast |
|
4 | general cells |
IFO50417 |
3T3-Swiss albino |
mouse |
embryo |
fibroblast, contact inhibited, (Swiss albino mouse) |
|
5 | general cells |
JCRB0007 |
Pt K2 |
marsupial (potoroo, rat kangar |
kidney |
DNA replication study |
|
6 | general cells |
JCRB0017 |
P388 |
mouse |
|
MCA induced lymphoid mouse neoplasma cell line. |
|
7 | general cells |
JCRB0033 |
CCRF-CEM |
human |
peripheral blood (buffy coat) |
leukemia, acute T lymphoblastic |
|
8 | general cells |
JCRB0035 |
RPMI 1788 |
human |
peripheral blood |
established from normal blood, IgM secreting |
|
9 | general cells |
JCRB0062 |
HEL |
human |
peripheral blood |
leukemia, erythroid |
|
10 | general cells |
JCRB0091 |
P31/FUJ |
human |
peripheral blood |
leukemia, acute monocytic |
|
11 | general cells |
JCRB0097 |
A4/Fuk |
human |
ascites |
lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing |
|
12 | general cells |
JCRB0143.1 |
F2408 EBNA2 cl-9 |
rat |
whole body of embryo |
EBNA2-transfected, (Fischer rat) |
|
13 | general cells |
JCRB0150 |
P53LMACO1 |
mouse |
thoracic aorta |
Smooth muscle cell line established from thoracic aorta of a p53 knock out mouse. |
|
14 | general cells |
JCRB0153.2 |
tsJT16 |
rat |
embryo |
Rat 3Y1 derived ts mutant cell line for cell cycle progression from G0 and G1 to S phase. |
|
15 | general cells |
JCRB0174.0 |
NCC16-P11 |
human |
endocervix |
Normal human endo-cervical columner cells immortalized by HPV16 virus genome and no tumor formation observed in nude mice. Growth is not dependent to EGF. |
|
16 | general cells |
JCRB0214 |
HeLa TG |
human |
cervix |
epitheloid carcinoma, 6-thioguanine-resistant |
|
17 | general cells |
JCRB0610 |
IAR-20 |
rat |
liver |
non-transformed live cell line, (BD-IV rat) |
|
18 | general cells |
JCRB0730 |
A9(2621)-4 |
human chromosome-introduced |
hybrid |
contains human chromosome 12pter>12q24::Xq22>Xqter (MTA with Tottori Univ. is required.) |
|
19 | general cells |
JCRB0741 |
NG-3Y1-T6R |
rat |
embryo/fetus whole body |
3Y1 derivative, transformed by MNNG, (Fischer rat) |
|
20 | general cells |
JCRB0818 |
SBC-3 |
human |
lung |
small cell carcinoma, oat cell type |
|
21 | general cells |
JCRB0832 |
NH-6 |
human |
adrenal gland |
neuroblastoma, adrenal gland, opsomyoclonus, truncal ataxia |
|
22 | general cells |
JCRB1009 |
RERF-GC-1B |
human |
stomach |
Human gastric cancer cell line established from a metastatic tissue of pyloric lymph nodes. |
|
23 | general cells |
JCRB1014 |
KMRM-M1 |
human |
muscle |
Human renal cancer cell line metastasized to muscle. |
|
24 | general cells |
JCRB1022 |
OUMS-23 |
human |
colon |
A human colon carcinoma cell line established from metastatic pericardial fluid. |
|
25 | general cells |
JCRB1040 |
FF101 |
rat |
liver |
Rat hepatoma cell line with producing unidentified growth factor maintained in serum-free RPMI1640 medium for 444 passages. |
|
26 | general cells |
JCRB1183 |
NCC-RbC-54 |
human |
primary retinoblastoma |
Human retinoblastoma cell line. The growth is extremely slow. |
|
27 | general cells |
JCRB1208 |
HM-1 |
hamster, Syrian |
lymph node |
Hamster macrophage cell line from Syrian hamster transplanted with human umbilical cord leukocytes. |
|
28 | general cells |
JCRB1222.09 |
HGH1.15.3 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
29 | general cells |
JCRB1614 |
hTf26-9B/sf |
mouse x mouse |
|
This cell line produce monoclonal antibody against human transferrin. |
|
30 | luciferase-expressing cancer cells |
JCRB1685 |
HSC-3 CMV-Luc |
human |
|
Luciferase stably expressing cell line
(HSC-3;Human oral squamous carcinoma cell line with high metastatic potential cell line). |
|
31 | genetically-modified cells |
JCRB1735 |
293_hSyn4 |
human |
kidney |
293 cell line into which human Syndecan-4 gene has been transfected. |
|
32 | general cells |
JCRB1778 |
KKU-023 |
human |
|
Human well differentiated cholangiocarcinoma cell line established from biliary tract. |
|
33 | general cells |
JCRB1883 |
KE-3 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
34 | general cells |
JCRB1900 |
Sui66 |
human |
pancreas |
Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from pancreas adenocarcinoma. |
|
35 | general cells |
JCRB2215 |
A9(Neo15) |
human chromosome-introduced |
skin |
contains human chromosome #15 (MTA with Tottori Univ. is required.)
|
|
36 | general cells |
JCRB9019 |
3T3-Swiss albino |
mouse |
embryo |
fibroblast, contact inhibited, (Swiss albino mouse) |
|
37 | general cells |
JCRB9029 |
MDCK (NBL-2) |
dog |
kidney |
established from normal kidney, susceptible for many viral species |
|
38 | general cells |
JCRB9055 |
R2C |
rat |
testicular tumor |
Leydig cell testicular tumor,steroid secreting |
|
39 | general cells |
JCRB9106 |
MPC 11 OUAr |
mouse |
|
myeloma, ourbain resistant |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.